Entity
  • NovAliX

    Created in 2002
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    300 14,565
  • Activities

  • Technologies

  • Entity types

  • Location

    16 Rue d'Ankara, 67000 Strasbourg, France

    Strasbourg

    France

  • Employees

    Scale: 201-500

    Estimated: 382

  • SIREN

    444361851
  • Engaged corporates

    29
    4 27
  • Added in Motherbase

    5 years, 4 months ago
Description
  • Value proposition

    NovAliX is a preclinical drug discovery-focused CRO

    NovAliX is a fully integrated drug discovery CRO supporting therapeutic programs from target identification to the delivery of preclinical candidates. NovAliX enables successful discovery programs through an award-winning team of medicinal chemistry and pharmacology scientists, and a variety of screening and characterization technologies, including an outstanding DNA-encoded library platform and a comprehensive portfolio of biophysical techniques, including an in-house cryo-EM facility. NovAliX’s presence in therapeutic areas now spans oncology, inflammation, fibrosis, and infectious and kidney diseases. For additional information, please visit www.novalix.com

    Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Organic Chemistry, cryo-electron microscopy, Chemical development, Medicinal chemistry, Structural Biology, in vitro pharmacology, DNA-encoded libraries, Flow chemistry, and Chemical process research

  • Original language

    NovAliX is a preclinical drug discovery-focused CRO

    NovAliX is a fully integrated drug discovery CRO supporting therapeutic programs from target identification to the delivery of preclinical candidates. NovAliX enables successful discovery programs through an award-winning team of medicinal chemistry and pharmacology scientists, and a variety of screening and characterization technologies, including an outstanding DNA-encoded library platform and a comprehensive portfolio of biophysical techniques, including an in-house cryo-EM facility. NovAliX’s presence in therapeutic areas now spans oncology, inflammation, fibrosis, and infectious and kidney diseases. For additional information, please visit www.novalix.com

  • NovAliX - Preclinical CRO. Drug discovery services

    NovAliX is a preclinical CRO providing drug discovery services. Highly proficient in both chemistry and biophysics with unique technologies

  • https://novalix.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Bristol Myers Squibb
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Bristol Myers Squibb
Pharmaceutical, Pharmaceutical Manufacturing
Other

13 Aug 2024


ANCTerritoires ANCTerritoires
Other

30 Sep 2022


GSK
GSK
Pharmaceutical, Pharmaceutical Manufacturing
GSK
Pharmaceutical, Pharmaceutical Manufacturing
Other

20 Mar 2024


Roche
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Roche
Pharmaceutical, Biotechnology, Biotechnology Research
Other

17 Jan 2024


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

20 Mar 2024


Johnson & Johnson
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Johnson & Johnson
Pharmaceutical, Hospitals and Health Care
Other

26 Apr 2024


360 Grand Est
360 Grand Est
Trade show, Events Services
360 Grand Est
Trade show, Events Services
Other

22 Jun 2023


Institut Curie
Institut Curie
Health, Hospitals and Health Care
Institut Curie
Health, Hospitals and Health Care
Other

23 May 2023


Merck Group
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing
Merck Group
Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing
Other

23 May 2023


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Other

20 Mar 2024


Similar entities
Loading...
Loading...
Social network dynamics